Status | Study |
Active, not recruiting |
Study Name: A Study of ADX-102 in Subjects With Allergic Conjunctivitis Condition: Conjunctivitis, Allergic Date: 2016-12-14 Interventions: Drug: ADX-102 Ophthalmic Drops (0.5%) |
Recruiting |
Study Name: Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea Condition: Conjunctivitis, Allergic Date: 2015-09-18 Interventions: Drug: Alcaftadine Ophthalmic Solution 0.25% Alcaftadine Ophthalmic Solution 0.25% (Lastacaft®) as p |
Completed |
Study Name: AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis Condition: Conjunctivitis, Allergic Date: 2014-06-09 Interventions: Drug: AGN-229666 One drop of A |
Completed |
Study Name: AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis Condition: Conjunctivitis, Allergic Date: 2014-03-06 Interventions: Drug: AGN-229666 One to two drops of AGN-229666 twice daily in each eye for 10 weeks. |
Completed |
Study Name: A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1) Condition: Allergic Conjunctivitis Date: 2014-03-04 Interventions: Drug: Active Comparator EBI-005 5 mg/mL Dr |
Completed |
Study Name: Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis Condition: Allergic Conjunctivitis Date: 2014-03-04 Interventions: Drug: AL-53817 Ophthalmic Solution, 0.1% D |
Completed |
Study Name: Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea Condition: Conjunctivitis, Allergic Date: 2013-11-13 Interventions: Drug: Relestat Ophthalmic Solution 0.05% Relestat Ophthalmic Solution 0.05% prescribed as local standard |
Terminated |
Study Name: Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis Condition: Allergic Conjunctivitis Date: 2013-05-20 Interventions: Drug: hydrocortisone ophthalmic ointment 0.5% |
Completed |
Study Name: Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis Condition: Allergic Conjunctivitis Date: 2012-12-04 Interventions: Drug: AL-4943A ophthalmic solution Drug: O |
Completed |
Study Name: A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis Condition: Conjunctivitis, Allergic Date: 2012-11-19 Interventions: Drug: Alcaftadine 0.25% One dr |